UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

(Amendment No. 1)

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 18, 2015

 

  Synergy CHC Corp.  

 

  (Exact name of registrant as specified in its charter)  

 

Nevada   000-55098   99-0379440
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
ID Number)

 

865 Spring Street, Westbrook, ME   04092
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (615) 939-9004

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
   

 

EXPLANATORY NOTE

 

This Current Report on Form 8-K/A (Amendment No. 1) amends the Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) by Synergy CHC Corp. on August 21, 2015 (the “Original 8-K”) announcing the closing on August 18, 2015 of a contribution agreement with Hand MD Corp., a Delaware corporation, where we acquired 50% of Hand MD Corp.’s outstanding securities (the “Acquisition”). Simultaneously, Hand MD, LLC, a California limited liability company, entered into a Contribution Agreement with Hand MD Corp., the principal owners of Hand MD, LLC, and us whereby Hand MD LLC contributed to Hand MD Corp. all of its right, title and interest in its intellectual property and inventory associated with skincare, nail care and nail polish products (the “Hand MD Properties”) in exchange for the other 50% of Hand MD Corp.’s outstanding capital securities.

 

In the Original 8-K, we indicated that we would file the historical and pro forma financial information required under Item 9.01 with respect to the Acquisition within 71 days of the due date of the Original 8-K, as permitted by the SEC rules. The Company has considered the guidance pursuant to Rule 11-01(d) of Regulation S-X and related interpretations and has concluded the acquisition of the Hand MD Properties is the acquisition of assets and not of a business. Accordingly, we will not be filing historical financial statements as indicated in the Original 8-K. We are now filing this Amendment No. 1 to include the required pro forma financial information as a result of the completion of the Acquisition.

 

Item 9.01. Financial Statements and Exhibits.

 

(a) Financial statements of businesses acquired.
   
  Not applicable.
   
(b) Pro forma financial information.

 

The unaudited pro forma balance sheet of our company as of June 30, 2015 as if the Acquisition had occurred at June 30, 2015, is filed herewith as Exhibit 99.1 and is incorporated herein by reference.

 

(c) Shell company transactions.
   
  Not applicable.
   
(d) Exhibits

 

  Exhibit No.   Description
       
  99.1   Unaudited pro forma balance sheet of our company as of June 30, 2015.

 

 
   

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SYNERGY CHC CORP.
   
Date: November 3, 2015 /s/ Jack Ross
  Jack Ross
  President and Chief Executive Officer

 

 
   



 

Exhibit 99.1

 

Synergy CHC Corp.

(formerly Synergy Strips Corp.)

Pro Forma Consolidated Balance Sheets

(unaudited)

 

   June 30, 2015   Pro Forma   Reference   Pro Forma  
   As Reported   Adjustments   No.   Consolidated 
Assets                    
Current Assets:                    
Cash and cash equivalents  $637,238   $(105,767)   (1)  $531,441 
Accounts Receivable   1,720,385              1,720,385 
Receivable from related party   168,197              168,197 
Prepaid expenses   73,661              73,661 
Inventory   391,130    105,767    (1)   496,927 
Total Current Assets   2,990,611    -         2,990,611 
                     
Fixed assets, net   1,441              1,441 
Goodwill   2,923,047              2,923,047 
Intangible assets, net   2,862,090    1,500,000    (2)   4,362,090 
Debt issuance cost, net   225,693              225,693 
Total Assets  $9,002,882    1,500,000        $10,502,882 
                     
Liabilities and Stockholders’ Equity (Deficit)                    
Current Liabilities:                    
Accounts payable and accrued liabilities  $1,263,012             $1,263,012 
Notes payable, related party   -              - 
Current portion of long-term debt   750,000              750,000 
Current portion of long-term debt, related party   300,000              300,000 
Total Current Liabilities   2,313,012    -         2,313,012 
                     
Long-term Liabilities:                    
Note payable   750,000              750,000 
Note payable, net of debt discount, related party   5,130,561              5,130,561 
Total Long-term Liabilities   5,880,561    -         5,880,561 
Total Liabilities   8,193,573    -         8,193,573 
                     
Commitments and contingencies   -              - 
                     
Stockholders’ Equity (Deficit):                    
Common stock, $0.00001 par value; 75,000,000 shares authorized; 67,095,187 and 62,100,000 shares issued and outstanding, respectively   671              671 
Common stock to be issued   64,000    1,500,000    (2)   1,564,000 
Additional paid in capital   4,382,469              4,382,469 
Accumulated deficit   (3,637,831)             (3,637,831)
Total stockholders’ equity (deficit)   809,309    1,500,000         2,309,309 
Total Liabilities and Stockholders’ Equity (Deficit)  $9,002,882    1,500,000        $10,502,882 

 

 

(1) To record cash paid for Hand MD inventory.

(2) To record acquisition of intangible property in exchange for 2,142,857 shares of common stock valued at $0.70 per share.

 

 
 

 

Synergy CHC (CE) (USOTC:SNYR)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Synergy CHC (CE) Charts.
Synergy CHC (CE) (USOTC:SNYR)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Synergy CHC (CE) Charts.